Targeting MET Amplification as a New Oncogenic Driver

Certain genetically defined cancers are dependent on a single overactive oncogene for their proliferation and survival, a phenomenon known as “oncogene addiction”. A new generation of drugs that selectively target such “driver oncogenes” manifests a clinical efficacy greater than that of conventiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawakami, Hisato, Okamoto, Isamu, Okamoto, Wataru, Tanizaki, Junko, Nakagawa, Kazuhiko, Nishio, Kazuto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190554/
https://www.ncbi.nlm.nih.gov/pubmed/25055117
http://dx.doi.org/10.3390/cancers6031540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190554/
https://www.ncbi.nlm.nih.gov/pubmed/25055117
http://dx.doi.org/10.3390/cancers6031540

Ejemplares similares